Issue: January 2017
January 10, 2017
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Trial Scorecard: PACE
Issue: January 2017
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Researchers assessed the safety and efficacy of injecting aldehyde dehydrogenase bright cells into the affected areas of patients with claudication.